Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07312890
Recruiting Not applicable

Bedside Observation by Clinical Ultrasound for Stomach Expansion

NCT07312890 · tracked via the Priya Life Science France tracker
Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Phase
Not applicable
Started
2025-10-25
Last updated
2025-12-31

Condition(s) studied

Enteral Feeding Intolerance

Investigational drug(s) / intervention(s)

Gastric ultrasound with measurement of the antral area

Gastric ultrasound with measurement of the antral area: Gastric ultrasound with measurement of the antral area

Study summary

The objective of the BOCUSE study is to demonstrate a relationship between an early ultrasound measurement of the gastric antral area and the subsequent occurrence of poor gastric tolerance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Predicted mechanical ventilation ≥ 48 hours * Initiation of enteral nutrition via nasogastric or orogastric tube for ≥ 48 hours * Free and informed consent obtained from the patient's relative or legal representative, or inclusion in an emergency situation Exclusion Criteria: * History of major gastric surgery (bypass, total gastrectomy, biliopancreatic diversion) * Enteral nutrition via nasogastric or orogastric tube \> 96 hours * Initiation of enteral nutrition before intubation * Feeding via gastrostomy, jejunostomy, or jejunal tube * Pregnancy * Prognosis considered terminal * No ultrasound window available * Legally protected adults (under curatorship, guardianship, or judicial protection) * No social security coverage * Patient under State Medical Aid (AME)

Primary outcome measure(s)

  • Enteral nutrition intolerance — Within 7 days following the gastric ultrasound
    Presence of regurgitation and/or vomiting and/or interruption or reduction of enteral nutrition flow rates

Trial sites (1)

FacilityCityRegionStatus
Hôpital Saint Joseph Saint Luc Lyon France Recruiting

More Centre Hospitalier Saint Joseph Saint Luc de Lyon trials in France

Ultra-portable Ultrasound vs. Standard Ultrasound to Help Place a Peripheral Catheter in Patients at Risk of Difficult Puncture Recruiting
Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation Recruiting
Titration of Positive End-expiratory Pressure: Comparison Between Manual Thoracic or Abdominal Compression and Electrical Impedance Tomography Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07312890 on ClinicalTrials.gov ↗ ← All trials in France